Home » Dispatches »

David, Goliath and Malcolm Gladwell

Sling_shot

Malcolm Gladwell, whose latest best-seller is called “David and Goliath,” is incapable of writing anything as sharp as this riff from Agatha Christie’s autobiography:

“Only a year or two ago, standing on the mound at Nimrud, I watched the local bird-scarer, an old Arab with his handful of stones and his sling, defending the crops from the hordes of predatory birds. Seeing his accuracy of aim and the deadliness of his weapon, I suddenly realised for the first time that it was Goliath against whom the dice were loaded. David was in a superior position from the start —the man with a long-distance weapon against the man who had none. Not so much the little fellow against the big one, as brains versus brawn.”

People have begun to get wise to Gladwell. He hit the scene in 1997 with a big article in the New Yorker, “The Estrogen Question: How Wrong is Dr. Susan Love?”   Why, I asked a knowledgable friend, did the New Yorker publish a paean to hormone replacement therapy by a kid who knew nothing about medicine, let alone menopause. She replied: “He’s Jacob Weissberg’s roommate.”  (She assumed I knew that Jacob Weissberg was an editor at the New Republic, which was then a Triple-A farm club for the NYer.)
 
Susan Love, a distinguished clinician and UCLA professor, had been publicizing The Nurse’s Health Study finding that women taking Wyeth’s Prempro had a higher rate of breast cancer. Gladwell derided her warnings. His piece culminated in a plug for Eli Lilly’s new drug Raloxifene, which was about to be marketed as Evista. “Before very long,” wrote young Gladwell, “women worried about raising their breast-cancer risk will have the option of taking a different kind of hormone that doesn’t affect their breasts at all —or that may even protect against breast cancer.”

Raloxifene, Gladwell explained, represented “the next generation of HRT, the compounds known as serms (for ‘selective estrogen receptor modulators’).”  It was obvious that Eli Lilly, having made billions off its “selective serotonin reuptake inhibitor” anti-depressant Prozac, was reapplying the patter to its HRT drug. Gladwell scolded Love for not applauding the advent of serms: “You might think that it would be of enormous significance to Love, answering, as it does, her great worry about the potential side effects of HRT.” The lad’s tone was coolly condescending throughout. “What Love has done is recalculate the risk-benefit equation for estrogen,” he asserted, “which is fine, except that she consistently overstates the risks and understates the benefits.”

Gladwell’s defense of HRT was/is a textbook example of corporate damage control.

When the harmful effects of a product have been exposed by a study, step #1 is to cite other studies drawing favorable conclusions. To this end Gladwell quotes an epidemiologist named Trudy Bush: “I just reviewed the hormone/breast-cancer research from the last five years,” Gladwell quotes an epidemiologist named Trudy Bush: “I found four reports —two very large and well done— showing no effect, and I found another study showing that estrogen gave women significant protection against breast cancer. They’re all over the place.” Claiming that existing studies are inconclusive and that more research is needed sounds reasonable and usually gives the drug company 10 extra marketing years. In the case of Prempro, Wyeth only got five because the leaders of the Women’s Health Initiative had seen enough by 2002.

Step #2 is to attack the methodology of the revealing study. Gladwell faults the Nurses Health Study for “selection-bias problems. The estrogen users, for example, had fewer pregnancies, got their periods earlier, and have other differences with the control group which would lead you believe that they might have had a higher risk of breast cancer anyway. There is another possible complication: estrogen does such a good job of fighting heart disease that most women who are on HRT live substantially longer than women who aren’t.” (That’s Step #3, the Bold Inversion. Gladwell was probably spoon-fed by the same Lilly flack who reasoned that Prozac leads to suicide because it enables severely depressed people to overcome their lethargy.)

Step #4 is simply smearing the messenger. If a researcher’s professional credentials are unassailable, there’s always guilt by association. Just as Lilly (falsely) linked their foremost critic, Peter Breggin, MD, to the Scientologists, Gladwell puts Love in a vaguely disreputable “media-celebrity” category. “Her objection,” he writes, “is to the idea that postmenopausal women should rely on any sort of drug at all. This is where, sooner or later, you end up when you start down the path of people like Andrew Weil and Deepak Chopra and Susan Love.”

In a 2001 article by Gladwell extolling the anti-malarial effects of DDT, the woman who had gotten her science wrong was Rachel Carson. DDT, according to the man Gladwell touted as the great authority, “ought to be used as selectively as possible, to quell major outbreaks,” i.e., the present ban should be rescinded.

The massive, worldwide application of DDT had been promoted in the 1940s and ’50s by a Rockefeller Foundation functionary named Fred Soper who, according to Gladwell, “ranks as one of the unsung heroes of the twentieth century.” As it became clear that worldwide eradication was impractical ­because DDT-resistant mosquito strains had developed, Soper discounted all evidence of failure. Gladwell describes Soper losing his temper at one meeting in response to “talk that was impeding eradication —the doubting, the equivocation, the incompetence, the elevation of songbirds over human life.”

In 2002, as data from the Women’s Health Initiative confirmed that women taking HRT are more likely to get breast cancer, blogger Mickey Kaus quoted some of Gladwell’s putdowns of Love and asked if he stood by his NYer piece. Gladwell emailed: “i was waiting for someone to write that! okay, here’s my answer: kausfiles is quite right. i was wrong, and susan love ought to feel vindicated. this is the perilous–and, of course, fun– part of writing about medicine. every now and again, scientists discover something new that turns everything we all thought we understood upside down.”

This was a bizarre and revealing  response —as if what was at stake were Susan Love’s feelings, not the well-being of the women who started hormone replacement therapy or chose to stay on it thanks to his misleading New Yorker piece. Malcolm Gladwell, author of best-sellers, may know jack about science but he knows plenty about promoting ideas and products. If he regretted having advised women to take cancer-causing drugs, he should have seen to it that a retraction was widely disseminated instead of burying a comment on kausfiles, where it didn’t even warrant an item unto itself. And how about his “waiting” to be called out? Translation: “i was hoping no one would remember.”

Gladwell, a lightweight, is not entirely to blame for the damage his HRT article may have done. The New Yorker should not have run it in 1997 and had an obligation in 2002 to notify readers that their reporting on “the estrogen question” had been wrong. 

 

Support O’Shaughnessy’s

"From each according to their ability, to each according to their need." 

O’S Available Here

O’S First E-Book – Available Now!

Recommended Reading

Plugs

Prop 215 Ballads – Fred Gardner’s CD Medical Cannabis Videos

Our Entourage

Best newspaper in America Dr. Tod – The Movie The Society of Cannabis Clinicians was formed as a project of the California Cannabis Research Medical Group in the Autumn of 2004. Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD) and other components of the Cannabis plant. News and political analysis Dr. Lester Grinspoon, M.D. is Associate Professor Emeritus of Psychiatry at Harvard Medical School. Dr. Grinspoon was senior psychiatrist at the Massachusetts Mental Health Center in Boston for 40 years. Moving Sustainable Medicines Forward Consultant VaporNation Newhead News Political allies CRAFT Law Office Omar CBD specialists
"Experience is useless without memory."
—Martha Gellhorn

The Second Column

Oysters in Lake Merritt?

Mussels, barnacles  and other marine growth clog the grates at the Lake Merritt Flood Control Facility pump station on the West end of the lake in Oakland, Calif., Thursday, Nov. 6, 2014. Alameda County public works has hired a commercial dive team for an emergency job to clear the pumps before the rainy season. (Anda Chu/Bay Area News Group)

November 7, 2014   There is hope after all! A terrific piece by Matt O’Brien in the Oakland Tribune describes the return of marine life to Lake Merritt (an estuary …

Deputy AG Cole Threatens California Medical MJ Providers (and Users)

Deputy AG James M. Cole

From  O’Shaughnessy’s New Service, October 16, 2014       After Colorado and Washington state voters passed “legalization” initiatives in November, 2012, there was some doubt that the federal government would allow …

Warrantless Raids in Lake County Ruled Unconstitutional

Joe Elford a few years ago.

by the great Thelton Henderson, the federal judge who has held the Oakland Police Department to account for corrupt marauding. October 15, 2014   Federal District Court Judge Thelton Henderson …

California NORML: No on 46!

California NORML's Dale Gieringer

October 7, 2014  Dale Gieringer of California NORML has written to the Friends Committee on Legislation decrying their support for a proposition (46) placed on the November ballot …

CJCJ Study Exposes Under-21 Prohibition

Wonder Woman with Scales of Justice

September 29    We hope the Center on Juvenile and Criminal Justice report released this week will start marijuana reformers questioning the wisdom of Under-21 Prohibition.   This is from …

California MDs Deplore Prop 46

Loyd-ad

At the Society of Cannabis Clinicians meeting Sept. 21, Dale Gieringer of California NORML directed the doctors’ attention to a ballot measure to which he is strongly opposed …

That Benefit Was Not Unexpected

From graphic by Olimpia Zagnoli for the NY Times

August 30  To the New York Times Dr. Marcus Bachhuber and Colleen Barry, summarizing their important study in the Times, write that they asked “Could the availability of medical marijuana reduce …

The Latest Plague (Aculops cannabicola)

russet mites on leaf 2009 by Karl Hillig

From A.J., a “mom-and-pop” grower in Northern California, September 7, 2014 I saw that you wrote an article about a trimmer getting sick from Avid. Well I thought …

Dr. O’Shaughnessy in India

Line drawing of O’Shaughnessy and Dr. Gopal Chandra Roy from the History of Medical Science: Influence of Western Education in 19th Century Bengal. Roy, who attended Calcutta Medical College, published a paper ‘On the solvent action of Papaya juice on the nitrogenous articles of food’ in the Glasgow Medical Journal (1874) —thought to be the first article by a native Indian published in a foreign journal.

From the upcoming print edition:   It was William Brooke O’Shaughnessy, MD, sent to Bengal by the British East India Company in the 1830s, who informed European physicians …

DEA Moves Hydrocodone to Schedule II

Vicodin

  August 22, 2014   The Drug Enforcement Administraton has moved “all pharmaceuticals containing hydrocodone currently on the market in the United States”  from Schedule III to Schedule II …

Access to Medical Marijuana Leads to Fewer Opioid OD Deaths

THM 21_1

August 25 2014  JAMA Internal Medicine today published a study by Marcus A. Bachhuber, MD and colleagues documenting that states that have legalized marijuana for medical use have “significantly …

Seattle Hempfest Adding Over-21 Smoking Sections

George Van Patten, DJ Short and Martin Lee at the Project CBD booth.

August 13, 2014   By Fred Gardner Seattle’s first retail outlet for marijuana opened in July, some 20 months after Washington state voters passed Initiative 502. Legalization as defined …

Public Health Service Approves Sisley’s PTSD Study

Sue Sisley

March 14, 2014      This is said to be a big, big breakthrough. Here’s the relevant background. And here’s the latest from Evan Halper (from Washington) and Cindy …

They’re Allowed to Shoot Children on the Street

Andy Lopez —photo by Bridgett Roque

From O’S News Service July 8, 2014 Last October a Sonoma County Sheriff’s Deputy —an Iraq vet named Erick Gelhaus— fired seven rounds into a 13-year-old named Andy Lopez who was …

On “Runner’s Joy”

Men's Health Cover

From Greg Gerdeman, July 8: My little Men’s Health info graphic on runner’s high is out. I didn’t do the design. Get your souvenir copies on magazine stands …

Sophie’s Progress

Dad, Sophie, Mom

From Tracy Ryan, June 24, 2014   Sophie has been on high concentrated THC and CBD cannabis oil at a gram a day since she started chemo in October of …

Cannabis vs Glioma: Another Encouraging ‘Anecdote’

Sophie Ryan

From Bonni Goldstein, MD, June 20, 2014 I have a patient who is almost two years old who has a terrible brain tumor called an “Optic Pathway Glioma.” …

Plant Geneticist Seeking Unhybridized Strains

Jon Page (right) with Alexander Makryannis at the 2011 ICRS meeting.

From Robert Sutherland of the Humboldt-Mendocino Marijuana Advisory Project June 23, 2014 At the Hummap meeting in Redway yesterday, the main agenda item revolved around genetics, and the …

Introducing ‘Cannabis as a Substitute for Alcohol’

THM 21_1

By Fred Gardner   June 18 WeedMaps is planning to post O’Shaughnessy’s Greatest Hits, starting with Tod Mikuriya’s paper “Cannabis as a Substitute for Alcohol” (2003). The name of Tod Mikuriya, …

Cole/Anslinger

Deputy AG James M. Cole

Leaders of the marijuana industry greatly appreciated the line Deputy Attorney General James M. Cole took in 2013 when he told Congress: “The Department of Justice expects that states …